Physician profile
Allison K West
NPI 1528019676
$391.36
in general payments reported to CMS, 2019-2025
13 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $85.18 · 2022: $40.47 · 2023: $121 · 2024: $32.92 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $71.71 | 2019 | |
| Abbvie INC. | $41.10 | 2019-2023 | Liletta |
| Exeltis, USA INC. | $33.82 | 2023-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $32.70 | 2023-2024 | |
| Sage Therapeutics, LLC | $32.51 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $31.88 | 2023-2025 | Paragard T 380a, Paragard T 380a |
| Exact Sciences Corporation | $27.69 | 2025 | Cologuard Collection Kit |
| Myovant Sciences INC. | $27.30 | 2022 | |
| Mayne Pharma Commercial LLC | $24.70 | 2023 | |
| Organon LLC | $18.09 | 2025 | Nexplanon |
| Gynesonics, INC. | $17.53 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Astellas Pharma US INC | $16.85 | 2025 | Veozah |
| Sumitomo Pharma America, INC. | $15.48 | 2023 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison West listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.